N/A
N=36
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
HIV/AIDS
Bottom Line
View on ClinicalTrials.gov: NCT04201288 ↗Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Number of Participants Meeting Retention in HIV Medical Care Guidelines at 52 Weeks — 20; 16 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Acceptance-Based Behavior Therapy (ABBT) (Behavioral); Enhanced-Treatment-as-Usual (ETAU) (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Brown University
- Primary completion
- Mar 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Meeting Retention in HIV Medical Care Guidelines at 52 Weeks |
20; 16 | — |
| PRIMARY Number of Participants Who Met HIV Virologic Suppression |
20; 14 | — |
| SECONDARY Self-Rating Scale Item (SRSI) - Antiretroviral Treatment Adherence |
4.5; 4.6 | — |
| SECONDARY Brief HIV Disclosure Scale (BHD) |
21.3; 22.1 | — |
| SECONDARY The Multidimensional Scale of Perceived Social Support (MSPSS) |
5.8; 5.3 | — |
| SECONDARY HIV Stigma Scale (HSS) |
19.5; 21.1 | — |
Summary
The overall aim of this program of research is to test a newly developed intervention, Acceptance-Based Behavior Therapy (ABBT), to improve HIV patients' commitment to medical care.
The purpose of the proposed project is to establish the efficacy of ABBT and examine its mechanisms of action. To achieve the specific aims, the investigators will conduct a randomized clinical trial (n = 270), with two treatment arms: ABBT vs. an attention-matched HIV education control condition.
Eligibility Criteria
Inclusion Criteria
- HIV+
- ≥18 years old
- Entering HIV medical care services for the first time (that is, not transferring HIV care from another location)
- Able to speak and read English at the level to be able to complete the study procedures
- Have telephone access.
Exclusion Criteria
- Cognitively impaired
Data sourced from ClinicalTrials.gov (NCT04201288). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.